Under a multi-year agreement, Covance will work with Lilly to deliver a centralized clinical monitoring solution for the company’s global clinical portfolio using Xcellerate® Monitoring, the latest addition to the Xcellerate® Informatics platform. With our breakthrough SaaS platform, now you can also proactively mitigate trial risks in near real time for a single study or your entire trial portfolio. |
| HOME PAGE | CONTACT US | |
XCELLERATE® MONITORING: REDUCE TRIAL COST, COMPLEXITY AND RISK WITH AN ELECTRIFYING SOLUTION FOR PORTFOLIO-WIDE MONITORING. |
|
Manage complexity. Optimize results. |